These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cerebral glucose metabolism associated with a fear network in panic disorder. Sakai Y; Kumano H; Nishikawa M; Sakano Y; Kaiya H; Imabayashi E; Ohnishi T; Matsuda H; Yasuda A; Sato A; Diksic M; Kuboki T Neuroreport; 2005 Jun; 16(9):927-31. PubMed ID: 15931063 [TBL] [Abstract][Full Text] [Related]
9. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. Modigh K; Westberg P; Eriksson E J Clin Psychopharmacol; 1992 Aug; 12(4):251-61. PubMed ID: 1527228 [TBL] [Abstract][Full Text] [Related]
10. Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. van den Heuvel OA; Veltman DJ; Groenewegen HJ; Witter MP; Merkelbach J; Cath DC; van Balkom AJ; van Oppen P; van Dyck R Arch Gen Psychiatry; 2005 Aug; 62(8):922-33. PubMed ID: 16061770 [TBL] [Abstract][Full Text] [Related]
11. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo. Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313 [TBL] [Abstract][Full Text] [Related]
12. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo. Sheikh JI; Swales PJ Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237 [TBL] [Abstract][Full Text] [Related]
13. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy. Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790 [TBL] [Abstract][Full Text] [Related]
14. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. Benkelfat C; Nordahl TE; Semple WE; King AC; Murphy DL; Cohen RM Arch Gen Psychiatry; 1990 Sep; 47(9):840-8. PubMed ID: 2393342 [TBL] [Abstract][Full Text] [Related]
15. SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Bremner JD; Innis RB; White T; Fujita M; Silbersweig D; Goddard AW; Staib L; Stern E; Cappiello A; Woods S; Baldwin R; Charney DS Biol Psychiatry; 2000 Jan; 47(2):96-106. PubMed ID: 10664825 [TBL] [Abstract][Full Text] [Related]
16. Imipramine for vestibular dysfunction in panic disorder: a prospective case series. Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE Arq Neuropsiquiatr; 2011 Apr; 69(2A):196-201. PubMed ID: 21537560 [TBL] [Abstract][Full Text] [Related]
17. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia. Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676 [TBL] [Abstract][Full Text] [Related]
18. Minnesota Multiphasic Personality Inventory correlates of panic disorder with agoraphobia: changes with treatment. Ito LM; Gorenstein C; Gentil V; Miyakawa E Braz J Med Biol Res; 1995 Sep; 28(9):961-5. PubMed ID: 8580883 [TBL] [Abstract][Full Text] [Related]
19. Chronic dizziness presenting in a patient with panic disorder: response to imipramine. Mezzasalma MA; Mathias Kde V; Nascimento I; Valença AM; Nardi AE Arq Neuropsiquiatr; 2009 Mar; 67(1):121-2. PubMed ID: 19330229 [No Abstract] [Full Text] [Related]